FRESENIUS KABI ONCOLOGY LTD Inactive Instrument
Fresenius Kabi Oncology Ltd Stock
Equities
INE575G01010
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - INR | - |
|
| 2016 | AstraZeneca sells rights to anaesthetics for up to $770 million | RE |
| 2015 | Fresenius SE KGaA : Kabi sells German oncology compounding business | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 18-06-30 | |
Rahul Sharma
DFI | Director of Finance/CFO | - | - |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 08-08-10 | |
| Director/Board Member | - | 07-07-20 | |
Maria Gobbi
CHM | Chairman | - | 14-11-12 |
| 1st Jan change | Capi. | |
|---|---|---|
| +4.07% | 111B | |
| +11.39% | 105B | |
| -13.04% | 22.34B | |
| -3.70% | 21.93B | |
| -6.03% | 18.59B | |
| -35.21% | 18.12B | |
| -10.29% | 16.96B | |
| +2.35% | 13.7B | |
| +36.16% | 12.45B |
- Stock Market
- Equities
- Stock